FDA fills four senior roles, including top officials for drugs, vaccines and tobacco
WASHINGTON (AP) — The administration of President Donald Trump filled four senior positions at the Food and Drug Administration on Tuesday, promoting several officials who had been serving in acting roles to permanently…
President Donald Trump's administration has filled four senior positions at the U.S. Food and Drug Administration (FDA) on Tuesday, providing the agency with greater stability following a period of significant change. The Department of Health and Human Services, which oversees the FDA, announced the permanent appointment of several officials, including the leaders in charge of drugs and vaccines.
Dr. Michael Davis has been named to lead the Center for Drug Evaluation and Research, the largest center within the FDA responsible for the safety and effectiveness of both prescription and over-the-counter drugs. Davis had previously held an acting role within the center since the departure of Dr. Tracy Beth Hoeg, who was fired in May. Hoeg's tenure primarily focused on reviewing antidepressants, COVID-19 vaccines, and other drugs used in children.
As the new head of the FDA's top drug regulator, Davis will oversee the review of several upcoming psychedelic drugs being studied for psychiatric conditions, such as psilocybin, MDMA, and LSD. Both Trump and Health Secretary Robert F. Kennedy have emphasized the urgency of accelerating the review of these drugs.
HHS also appointed Karim Mikhail to serve as the permanent director of the FDA's vaccines center. Mikhail, a pharmacist and former pharmaceutical executive, joined the FDA last spring and took over the position following the resignation of Dr. Vinay Prasad.
Written by urgent.news from Associated Press's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- FDA fills four senior roles, including top officials for drugs, vaccines and tobacco winnipegfreepress.com
